| scholarly article | Q13442814 |
| P50 | author | Behrooz Z. Alizadeh | Q41265465 |
| P2093 | author name string | L Hansen | |
| R Holl | |||
| P Hougaard | |||
| N C Schloot | |||
| H Kolb | |||
| B O Roep | |||
| A Kaas | |||
| C Pfleger | |||
| H B Mortensen | |||
| Hvidøre Study Group On Childhood Diabetes | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 57-65 | |
| P577 | publication date | 2008-04-22 | |
| P1433 | published in | Clinical Immunology | Q15752921 |
| P1476 | title | Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes | |
| P478 | volume | 128 |
| Q37601387 | Challenges in developing endpoints for type 1 diabetes intervention studies |
| Q33901377 | Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome |
| Q82537469 | Circulating cytokines are associated with human islet graft function in type 1 diabetes |
| Q39605597 | Effects of the genome on immune regulation in type 1 diabetes |
| Q26739691 | Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? |
| Q41751738 | Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression |
| Q45700874 | Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 dia |
| Q51060515 | Fatty acids modulate cytokine and chemokine secretion of stimulated human whole blood cultures in diabetes. |
| Q37777824 | Interference with islet-specific homing of autoreactive T cells: an emerging therapeutic strategy for type 1 diabetes |
| Q37799656 | Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society |
| Q34237695 | Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism |
| Q61478347 | Pro- and anti-inflammatory cytokines in latent autoimmune diabetes in adults, type 1 and type 2 diabetes patients: Action LADA 4 |
| Q35175990 | RANTES (CCL5) reduces glucose-dependent secretion of glucagon-like peptides 1 and 2 and impairs glucose-induced insulin secretion in mice |
| Q82950382 | Simultaneous evaluation of the circulating levels of both Th1 and Th2 chemokines in patients with autoimmune Addison's disease |
| Q82633280 | Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes |
| Q48829248 | Systemic levels of CCL2, CCL3, CCL4 and CXCL8 differ according to age, time period and season among children newly diagnosed with type 1 diabetes and their healthy siblings |
| Q92071317 | The Remission Phase in Type 1 Diabetes: Role of Hyperglycemia Rectification in Immune Modulation |
| Q24319758 | The novel chemokine receptor, G-protein-coupled receptor 75, is expressed by islets and is coupled to stimulation of insulin secretion and improved glucose homeostasis |
| Q28285897 | The pattern of inflammatory/anti-inflammatory cytokines and chemokines in type 1 diabetic patients over time |
| Q92170641 | The remission phase in type 1 diabetes: Changing epidemiology, definitions, and emerging immuno-metabolic mechanisms |
| Q37437153 | The role of inflammation in insulitis and beta-cell loss in type 1 diabetes |
| Q31132948 | The systemic immune network in recent onset type 1 diabetes: central role of interleukin-1 receptor antagonist (DIATOR Trial). |
| Q35123513 | Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes |
Search more.